Differentiation therapy of acute promyelocytic leukemia

Chinese Medical Journal

Volumn 109, Issue 3, 1996, Pages 179-182

  Chen, Zhu ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; CELL DEATH; CELL PROLIFERATION; DNA SEQUENCE; PHENOTYPE; SHORT SURVEY;

CELL DIFFERENTIATION; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; RECEPTORS, RETINOIC ACID; TRETINOIN;

EID: 0029987118     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (9)

1. Sachs, L. Control of normal differentiation and the phenotypic reversion of malignancy in myeloid leukemia cells. Nature 1978; 274:535.
2. Breitman TR, Selonick SE, Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 1980; 77:2936.
3. Smith MA, Parkinson DR, Cheson BD, et al. Retinoids in cancer therapy. J Clin Oncology 1992; 10:839.
4. Huang ME, Ye YC, Chen SR, et al. Use of all-transretinoic acid in treatment of acute promyelocytic leukemia. Blood 1988; 72:567.
5. Warrell RP, de The H, Wang ZY, et al. Acute promyelocytic leukemia. N Eng J Med 1993; 329:177.
6. Grignani F, Fagioli M, Alcalay M, et al. Acute promyelocytic leukemia: from genetics to treatment. Blood 1994; 83:10.
7. Chen SJ, Wang ZY, Chen Z. Acute promyelocytic leukemia: From clinic to molecular biology (Review article). Stem Cells 1995; 13:22.
8. National Cooperative Study Group on Treatment of Leukemias. Clinical study on all-trans retinoic acid in the treatment of 544 patients with acute promyelocytic leukemia. Chin J Hematol 1992; 13:135.
9. Leid M, Kastner P, Chambon P. Multiplicity generates diversity in the reinoic acid signalling pathways. Trends Biochem Sci 1992; 17:427.